nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—Paclitaxel—lung cancer	0.0992	0.184	CbGbCtD
Zoledronate—ABCC1—Irinotecan—lung cancer	0.0979	0.181	CbGbCtD
Zoledronate—ABCC1—Vinblastine—lung cancer	0.087	0.161	CbGbCtD
Zoledronate—ABCC1—Etoposide—lung cancer	0.0784	0.145	CbGbCtD
Zoledronate—ABCC1—Docetaxel—lung cancer	0.0718	0.133	CbGbCtD
Zoledronate—ABCC1—Doxorubicin—lung cancer	0.0535	0.0991	CbGbCtD
Zoledronate—ABCC1—Methotrexate—lung cancer	0.0518	0.096	CbGbCtD
Zoledronate—GGPS1—bronchus—lung cancer	0.00555	0.086	CbGeAlD
Zoledronate—GGPS1—trachea—lung cancer	0.00498	0.0772	CbGeAlD
Zoledronate—GGPS1—cardiac atrium—lung cancer	0.00468	0.0725	CbGeAlD
Zoledronate—GGPS1—bone marrow—lung cancer	0.00395	0.0612	CbGeAlD
Zoledronate—GGPS1—lung—lung cancer	0.00358	0.0555	CbGeAlD
Zoledronate—CA12—respiratory system—lung cancer	0.00314	0.0487	CbGeAlD
Zoledronate—FDPS—respiratory system—lung cancer	0.00311	0.0482	CbGeAlD
Zoledronate—CA14—cardiac atrium—lung cancer	0.0028	0.0434	CbGeAlD
Zoledronate—FDPS—bronchus—lung cancer	0.00256	0.0396	CbGeAlD
Zoledronate—GGPS1—lymph node—lung cancer	0.00245	0.038	CbGeAlD
Zoledronate—CA12—trachea—lung cancer	0.00232	0.036	CbGeAlD
Zoledronate—FDPS—trachea—lung cancer	0.0023	0.0356	CbGeAlD
Zoledronate—FDPS—cardiac atrium—lung cancer	0.00216	0.0334	CbGeAlD
Zoledronate—FDPS—bone marrow—lung cancer	0.00182	0.0282	CbGeAlD
Zoledronate—CA12—lung—lung cancer	0.00167	0.0259	CbGeAlD
Zoledronate—FDPS—lung—lung cancer	0.00165	0.0256	CbGeAlD
Zoledronate—CA2—respiratory system—lung cancer	0.00161	0.025	CbGeAlD
Zoledronate—ABCC1—bronchus—lung cancer	0.00149	0.023	CbGeAlD
Zoledronate—CA2—epithelium—lung cancer	0.00135	0.0209	CbGeAlD
Zoledronate—ABCC1—trachea—lung cancer	0.00133	0.0207	CbGeAlD
Zoledronate—CA2—bronchus—lung cancer	0.00133	0.0206	CbGeAlD
Zoledronate—ABCC1—cardiac atrium—lung cancer	0.00125	0.0194	CbGeAlD
Zoledronate—CA2—trachea—lung cancer	0.00119	0.0185	CbGeAlD
Zoledronate—FDPS—lymph node—lung cancer	0.00113	0.0175	CbGeAlD
Zoledronate—CA2—cardiac atrium—lung cancer	0.00112	0.0174	CbGeAlD
Zoledronate—ABCC1—lung—lung cancer	0.000958	0.0149	CbGeAlD
Zoledronate—CA2—bone marrow—lung cancer	0.000946	0.0147	CbGeAlD
Zoledronate—CA2—lung—lung cancer	0.000857	0.0133	CbGeAlD
Zoledronate—Risedronate—PTGS2—lung cancer	0.00083	0.529	CrCbGaD
Zoledronate—Clodronate—PTGS2—lung cancer	0.00074	0.471	CrCbGaD
Zoledronate—ABCC1—lymph node—lung cancer	0.000655	0.0102	CbGeAlD
Zoledronate—CA2—lymph node—lung cancer	0.000586	0.00908	CbGeAlD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000104	0.000311	CcSEcCtD
Zoledronate—Pain—Etoposide—lung cancer	0.000104	0.000309	CcSEcCtD
Zoledronate—Constipation—Etoposide—lung cancer	0.000104	0.000309	CcSEcCtD
Zoledronate—Neutropenia—Doxorubicin—lung cancer	0.000103	0.000308	CcSEcCtD
Zoledronate—Decreased appetite—Paclitaxel—lung cancer	0.000103	0.000308	CcSEcCtD
Zoledronate—Dry mouth—Docetaxel—lung cancer	0.000103	0.000306	CcSEcCtD
Zoledronate—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000103	0.000306	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000103	0.000305	CcSEcCtD
Zoledronate—Fatigue—Paclitaxel—lung cancer	0.000103	0.000305	CcSEcCtD
Zoledronate—Pollakiuria—Doxorubicin—lung cancer	0.000102	0.000304	CcSEcCtD
Zoledronate—Asthenia—Gemcitabine—lung cancer	0.000102	0.000303	CcSEcCtD
Zoledronate—Constipation—Paclitaxel—lung cancer	0.000102	0.000303	CcSEcCtD
Zoledronate—Pain—Paclitaxel—lung cancer	0.000102	0.000303	CcSEcCtD
Zoledronate—Confusional state—Docetaxel—lung cancer	0.000102	0.000302	CcSEcCtD
Zoledronate—Urinary tract disorder—Methotrexate—lung cancer	0.000101	0.0003	CcSEcCtD
Zoledronate—Oedema—Docetaxel—lung cancer	0.000101	0.0003	CcSEcCtD
Zoledronate—Anaphylactic shock—Docetaxel—lung cancer	0.000101	0.0003	CcSEcCtD
Zoledronate—Weight increased—Doxorubicin—lung cancer	0.000101	0.0003	CcSEcCtD
Zoledronate—Pruritus—Gemcitabine—lung cancer	0.0001	0.000299	CcSEcCtD
Zoledronate—Urethral disorder—Methotrexate—lung cancer	0.0001	0.000298	CcSEcCtD
Zoledronate—Infection—Docetaxel—lung cancer	0.0001	0.000298	CcSEcCtD
Zoledronate—Weight decreased—Doxorubicin—lung cancer	0.0001	0.000298	CcSEcCtD
Zoledronate—Feeling abnormal—Etoposide—lung cancer	9.99e-05	0.000297	CcSEcCtD
Zoledronate—Diarrhoea—Irinotecan—lung cancer	9.98e-05	0.000297	CcSEcCtD
Zoledronate—Gastrointestinal pain—Etoposide—lung cancer	9.92e-05	0.000295	CcSEcCtD
Zoledronate—Shock—Docetaxel—lung cancer	9.92e-05	0.000295	CcSEcCtD
Zoledronate—Nervous system disorder—Docetaxel—lung cancer	9.88e-05	0.000294	CcSEcCtD
Zoledronate—Thrombocytopenia—Docetaxel—lung cancer	9.87e-05	0.000294	CcSEcCtD
Zoledronate—Infestation NOS—Doxorubicin—lung cancer	9.86e-05	0.000293	CcSEcCtD
Zoledronate—Infestation—Doxorubicin—lung cancer	9.86e-05	0.000293	CcSEcCtD
Zoledronate—Tachycardia—Docetaxel—lung cancer	9.84e-05	0.000293	CcSEcCtD
Zoledronate—Feeling abnormal—Paclitaxel—lung cancer	9.8e-05	0.000292	CcSEcCtD
Zoledronate—Skin disorder—Docetaxel—lung cancer	9.79e-05	0.000291	CcSEcCtD
Zoledronate—Hypersensitivity—Cisplatin—lung cancer	9.75e-05	0.00029	CcSEcCtD
Zoledronate—Gastrointestinal pain—Paclitaxel—lung cancer	9.72e-05	0.000289	CcSEcCtD
Zoledronate—Diarrhoea—Gemcitabine—lung cancer	9.72e-05	0.000289	CcSEcCtD
Zoledronate—Renal failure—Doxorubicin—lung cancer	9.7e-05	0.000288	CcSEcCtD
Zoledronate—Dizziness—Irinotecan—lung cancer	9.64e-05	0.000287	CcSEcCtD
Zoledronate—Urticaria—Etoposide—lung cancer	9.64e-05	0.000287	CcSEcCtD
Zoledronate—Stomatitis—Doxorubicin—lung cancer	9.61e-05	0.000286	CcSEcCtD
Zoledronate—Anorexia—Docetaxel—lung cancer	9.61e-05	0.000286	CcSEcCtD
Zoledronate—Abdominal pain—Etoposide—lung cancer	9.59e-05	0.000285	CcSEcCtD
Zoledronate—Body temperature increased—Etoposide—lung cancer	9.59e-05	0.000285	CcSEcCtD
Zoledronate—Conjunctivitis—Doxorubicin—lung cancer	9.59e-05	0.000285	CcSEcCtD
Zoledronate—Urinary tract infection—Doxorubicin—lung cancer	9.59e-05	0.000285	CcSEcCtD
Zoledronate—Eye disorder—Methotrexate—lung cancer	9.56e-05	0.000284	CcSEcCtD
Zoledronate—Asthenia—Cisplatin—lung cancer	9.5e-05	0.000283	CcSEcCtD
Zoledronate—Cardiac disorder—Methotrexate—lung cancer	9.49e-05	0.000282	CcSEcCtD
Zoledronate—Urticaria—Paclitaxel—lung cancer	9.45e-05	0.000281	CcSEcCtD
Zoledronate—Hypotension—Docetaxel—lung cancer	9.42e-05	0.00028	CcSEcCtD
Zoledronate—Haematuria—Doxorubicin—lung cancer	9.4e-05	0.00028	CcSEcCtD
Zoledronate—Abdominal pain—Paclitaxel—lung cancer	9.4e-05	0.00028	CcSEcCtD
Zoledronate—Body temperature increased—Paclitaxel—lung cancer	9.4e-05	0.00028	CcSEcCtD
Zoledronate—Angiopathy—Methotrexate—lung cancer	9.28e-05	0.000276	CcSEcCtD
Zoledronate—Vomiting—Irinotecan—lung cancer	9.27e-05	0.000276	CcSEcCtD
Zoledronate—Immune system disorder—Methotrexate—lung cancer	9.24e-05	0.000275	CcSEcCtD
Zoledronate—Mediastinal disorder—Methotrexate—lung cancer	9.22e-05	0.000274	CcSEcCtD
Zoledronate—Agranulocytosis—Doxorubicin—lung cancer	9.2e-05	0.000274	CcSEcCtD
Zoledronate—Rash—Irinotecan—lung cancer	9.19e-05	0.000274	CcSEcCtD
Zoledronate—Dermatitis—Irinotecan—lung cancer	9.19e-05	0.000273	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Docetaxel—lung cancer	9.18e-05	0.000273	CcSEcCtD
Zoledronate—Chills—Methotrexate—lung cancer	9.18e-05	0.000273	CcSEcCtD
Zoledronate—Headache—Irinotecan—lung cancer	9.13e-05	0.000272	CcSEcCtD
Zoledronate—Insomnia—Docetaxel—lung cancer	9.12e-05	0.000271	CcSEcCtD
Zoledronate—Diarrhoea—Cisplatin—lung cancer	9.06e-05	0.00027	CcSEcCtD
Zoledronate—Paraesthesia—Docetaxel—lung cancer	9.05e-05	0.000269	CcSEcCtD
Zoledronate—Alopecia—Methotrexate—lung cancer	9.04e-05	0.000269	CcSEcCtD
Zoledronate—Vomiting—Gemcitabine—lung cancer	9.03e-05	0.000269	CcSEcCtD
Zoledronate—Bradycardia—Doxorubicin—lung cancer	9.01e-05	0.000268	CcSEcCtD
Zoledronate—Dyspnoea—Docetaxel—lung cancer	8.99e-05	0.000267	CcSEcCtD
Zoledronate—Somnolence—Docetaxel—lung cancer	8.96e-05	0.000267	CcSEcCtD
Zoledronate—Mental disorder—Methotrexate—lung cancer	8.96e-05	0.000267	CcSEcCtD
Zoledronate—Rash—Gemcitabine—lung cancer	8.96e-05	0.000266	CcSEcCtD
Zoledronate—Dermatitis—Gemcitabine—lung cancer	8.95e-05	0.000266	CcSEcCtD
Zoledronate—Hypersensitivity—Etoposide—lung cancer	8.94e-05	0.000266	CcSEcCtD
Zoledronate—Erythema—Methotrexate—lung cancer	8.9e-05	0.000265	CcSEcCtD
Zoledronate—Malnutrition—Methotrexate—lung cancer	8.9e-05	0.000265	CcSEcCtD
Zoledronate—Headache—Gemcitabine—lung cancer	8.9e-05	0.000265	CcSEcCtD
Zoledronate—Dyspepsia—Docetaxel—lung cancer	8.87e-05	0.000264	CcSEcCtD
Zoledronate—Hypoaesthesia—Doxorubicin—lung cancer	8.81e-05	0.000262	CcSEcCtD
Zoledronate—Decreased appetite—Docetaxel—lung cancer	8.76e-05	0.000261	CcSEcCtD
Zoledronate—Hypersensitivity—Paclitaxel—lung cancer	8.76e-05	0.000261	CcSEcCtD
Zoledronate—Urinary tract disorder—Doxorubicin—lung cancer	8.74e-05	0.00026	CcSEcCtD
Zoledronate—Oedema peripheral—Doxorubicin—lung cancer	8.72e-05	0.00026	CcSEcCtD
Zoledronate—Dysgeusia—Methotrexate—lung cancer	8.72e-05	0.000259	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Docetaxel—lung cancer	8.7e-05	0.000259	CcSEcCtD
Zoledronate—Asthenia—Etoposide—lung cancer	8.7e-05	0.000259	CcSEcCtD
Zoledronate—Connective tissue disorder—Doxorubicin—lung cancer	8.7e-05	0.000259	CcSEcCtD
Zoledronate—Fatigue—Docetaxel—lung cancer	8.69e-05	0.000259	CcSEcCtD
Zoledronate—Urethral disorder—Doxorubicin—lung cancer	8.68e-05	0.000258	CcSEcCtD
Zoledronate—Nausea—Irinotecan—lung cancer	8.66e-05	0.000258	CcSEcCtD
Zoledronate—Pain—Docetaxel—lung cancer	8.62e-05	0.000256	CcSEcCtD
Zoledronate—Constipation—Docetaxel—lung cancer	8.62e-05	0.000256	CcSEcCtD
Zoledronate—Back pain—Methotrexate—lung cancer	8.61e-05	0.000256	CcSEcCtD
Zoledronate—Pruritus—Etoposide—lung cancer	8.58e-05	0.000255	CcSEcCtD
Zoledronate—Asthenia—Paclitaxel—lung cancer	8.53e-05	0.000254	CcSEcCtD
Zoledronate—Nausea—Gemcitabine—lung cancer	8.44e-05	0.000251	CcSEcCtD
Zoledronate—Vomiting—Cisplatin—lung cancer	8.42e-05	0.00025	CcSEcCtD
Zoledronate—Pruritus—Paclitaxel—lung cancer	8.41e-05	0.00025	CcSEcCtD
Zoledronate—Vision blurred—Methotrexate—lung cancer	8.39e-05	0.00025	CcSEcCtD
Zoledronate—Rash—Cisplatin—lung cancer	8.35e-05	0.000248	CcSEcCtD
Zoledronate—Dermatitis—Cisplatin—lung cancer	8.34e-05	0.000248	CcSEcCtD
Zoledronate—Feeling abnormal—Docetaxel—lung cancer	8.31e-05	0.000247	CcSEcCtD
Zoledronate—Diarrhoea—Etoposide—lung cancer	8.3e-05	0.000247	CcSEcCtD
Zoledronate—Eye disorder—Doxorubicin—lung cancer	8.27e-05	0.000246	CcSEcCtD
Zoledronate—Ill-defined disorder—Methotrexate—lung cancer	8.26e-05	0.000246	CcSEcCtD
Zoledronate—Gastrointestinal pain—Docetaxel—lung cancer	8.24e-05	0.000245	CcSEcCtD
Zoledronate—Anaemia—Methotrexate—lung cancer	8.23e-05	0.000245	CcSEcCtD
Zoledronate—Cardiac disorder—Doxorubicin—lung cancer	8.22e-05	0.000244	CcSEcCtD
Zoledronate—Flushing—Doxorubicin—lung cancer	8.22e-05	0.000244	CcSEcCtD
Zoledronate—Diarrhoea—Paclitaxel—lung cancer	8.14e-05	0.000242	CcSEcCtD
Zoledronate—Angiopathy—Doxorubicin—lung cancer	8.03e-05	0.000239	CcSEcCtD
Zoledronate—Malaise—Methotrexate—lung cancer	8.03e-05	0.000239	CcSEcCtD
Zoledronate—Dizziness—Etoposide—lung cancer	8.02e-05	0.000239	CcSEcCtD
Zoledronate—Immune system disorder—Doxorubicin—lung cancer	8e-05	0.000238	CcSEcCtD
Zoledronate—Vertigo—Methotrexate—lung cancer	8e-05	0.000238	CcSEcCtD
Zoledronate—Mediastinal disorder—Doxorubicin—lung cancer	7.98e-05	0.000237	CcSEcCtD
Zoledronate—Abdominal pain—Docetaxel—lung cancer	7.97e-05	0.000237	CcSEcCtD
Zoledronate—Body temperature increased—Docetaxel—lung cancer	7.97e-05	0.000237	CcSEcCtD
Zoledronate—Leukopenia—Methotrexate—lung cancer	7.97e-05	0.000237	CcSEcCtD
Zoledronate—Chills—Doxorubicin—lung cancer	7.94e-05	0.000236	CcSEcCtD
Zoledronate—Arrhythmia—Doxorubicin—lung cancer	7.91e-05	0.000235	CcSEcCtD
Zoledronate—Dizziness—Paclitaxel—lung cancer	7.86e-05	0.000234	CcSEcCtD
Zoledronate—Nausea—Cisplatin—lung cancer	7.86e-05	0.000234	CcSEcCtD
Zoledronate—Alopecia—Doxorubicin—lung cancer	7.82e-05	0.000233	CcSEcCtD
Zoledronate—Cough—Methotrexate—lung cancer	7.77e-05	0.000231	CcSEcCtD
Zoledronate—Mental disorder—Doxorubicin—lung cancer	7.76e-05	0.000231	CcSEcCtD
Zoledronate—Convulsion—Methotrexate—lung cancer	7.71e-05	0.000229	CcSEcCtD
Zoledronate—Vomiting—Etoposide—lung cancer	7.71e-05	0.000229	CcSEcCtD
Zoledronate—Malnutrition—Doxorubicin—lung cancer	7.71e-05	0.000229	CcSEcCtD
Zoledronate—Erythema—Doxorubicin—lung cancer	7.71e-05	0.000229	CcSEcCtD
Zoledronate—CA12—Metabolism—CYP2A6—lung cancer	7.69e-05	0.00132	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GCLC—lung cancer	7.69e-05	0.00132	CbGpPWpGaD
Zoledronate—CA14—Metabolism—NQO1—lung cancer	7.67e-05	0.00132	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ABCC3—lung cancer	7.67e-05	0.00132	CbGpPWpGaD
Zoledronate—Rash—Etoposide—lung cancer	7.65e-05	0.000228	CcSEcCtD
Zoledronate—Dermatitis—Etoposide—lung cancer	7.64e-05	0.000227	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ATP5H—lung cancer	7.6e-05	0.00131	CbGpPWpGaD
Zoledronate—Headache—Etoposide—lung cancer	7.6e-05	0.000226	CcSEcCtD
Zoledronate—Chest pain—Methotrexate—lung cancer	7.58e-05	0.000225	CcSEcCtD
Zoledronate—Arthralgia—Methotrexate—lung cancer	7.58e-05	0.000225	CcSEcCtD
Zoledronate—Myalgia—Methotrexate—lung cancer	7.58e-05	0.000225	CcSEcCtD
Zoledronate—Vomiting—Paclitaxel—lung cancer	7.56e-05	0.000225	CcSEcCtD
Zoledronate—FDPS—Metabolism—ENO1—lung cancer	7.56e-05	0.0013	CbGpPWpGaD
Zoledronate—Dysgeusia—Doxorubicin—lung cancer	7.55e-05	0.000225	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	7.53e-05	0.0013	CbGpPWpGaD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.53e-05	0.000224	CcSEcCtD
Zoledronate—Rash—Paclitaxel—lung cancer	7.5e-05	0.000223	CcSEcCtD
Zoledronate—Dermatitis—Paclitaxel—lung cancer	7.49e-05	0.000223	CcSEcCtD
Zoledronate—Discomfort—Methotrexate—lung cancer	7.49e-05	0.000223	CcSEcCtD
Zoledronate—Back pain—Doxorubicin—lung cancer	7.46e-05	0.000222	CcSEcCtD
Zoledronate—Headache—Paclitaxel—lung cancer	7.45e-05	0.000222	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—ALB—lung cancer	7.44e-05	0.00128	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKR1C1—lung cancer	7.43e-05	0.00128	CbGpPWpGaD
Zoledronate—Hypersensitivity—Docetaxel—lung cancer	7.43e-05	0.000221	CcSEcCtD
Zoledronate—Muscle spasms—Doxorubicin—lung cancer	7.41e-05	0.00022	CcSEcCtD
Zoledronate—Confusional state—Methotrexate—lung cancer	7.33e-05	0.000218	CcSEcCtD
Zoledronate—CA12—Metabolism—ENO1—lung cancer	7.29e-05	0.00125	CbGpPWpGaD
Zoledronate—Anaphylactic shock—Methotrexate—lung cancer	7.26e-05	0.000216	CcSEcCtD
Zoledronate—Vision blurred—Doxorubicin—lung cancer	7.26e-05	0.000216	CcSEcCtD
Zoledronate—Asthenia—Docetaxel—lung cancer	7.23e-05	0.000215	CcSEcCtD
Zoledronate—Infection—Methotrexate—lung cancer	7.22e-05	0.000215	CcSEcCtD
Zoledronate—CA2—Metabolism—UGT1A1—lung cancer	7.21e-05	0.00124	CbGpPWpGaD
Zoledronate—Nausea—Etoposide—lung cancer	7.2e-05	0.000214	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—GNG11—lung cancer	7.19e-05	0.00124	CbGpPWpGaD
Zoledronate—Ill-defined disorder—Doxorubicin—lung cancer	7.15e-05	0.000213	CcSEcCtD
Zoledronate—Pruritus—Docetaxel—lung cancer	7.13e-05	0.000212	CcSEcCtD
Zoledronate—Nervous system disorder—Methotrexate—lung cancer	7.12e-05	0.000212	CcSEcCtD
Zoledronate—Anaemia—Doxorubicin—lung cancer	7.12e-05	0.000212	CcSEcCtD
Zoledronate—Thrombocytopenia—Methotrexate—lung cancer	7.11e-05	0.000212	CcSEcCtD
Zoledronate—Agitation—Doxorubicin—lung cancer	7.08e-05	0.000211	CcSEcCtD
Zoledronate—Nausea—Paclitaxel—lung cancer	7.06e-05	0.00021	CcSEcCtD
Zoledronate—Skin disorder—Methotrexate—lung cancer	7.06e-05	0.00021	CcSEcCtD
Zoledronate—Hyperhidrosis—Methotrexate—lung cancer	7.02e-05	0.000209	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	6.99e-05	0.0012	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GNG11—lung cancer	6.95e-05	0.0012	CbGpPWpGaD
Zoledronate—Malaise—Doxorubicin—lung cancer	6.95e-05	0.000207	CcSEcCtD
Zoledronate—Vertigo—Doxorubicin—lung cancer	6.93e-05	0.000206	CcSEcCtD
Zoledronate—Anorexia—Methotrexate—lung cancer	6.92e-05	0.000206	CcSEcCtD
Zoledronate—CA14—Metabolism—STK11—lung cancer	6.91e-05	0.00119	CbGpPWpGaD
Zoledronate—Syncope—Doxorubicin—lung cancer	6.91e-05	0.000206	CcSEcCtD
Zoledronate—Leukopenia—Doxorubicin—lung cancer	6.9e-05	0.000205	CcSEcCtD
Zoledronate—Diarrhoea—Docetaxel—lung cancer	6.9e-05	0.000205	CcSEcCtD
Zoledronate—GGPS1—Metabolism—PIK3CB—lung cancer	6.85e-05	0.00118	CbGpPWpGaD
Zoledronate—Palpitations—Doxorubicin—lung cancer	6.81e-05	0.000203	CcSEcCtD
Zoledronate—Hypotension—Methotrexate—lung cancer	6.79e-05	0.000202	CcSEcCtD
Zoledronate—GGPS1—Metabolism—PTGS2—lung cancer	6.79e-05	0.00117	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP2E1—lung cancer	6.78e-05	0.00117	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PLBD1—lung cancer	6.78e-05	0.00117	CbGpPWpGaD
Zoledronate—Loss of consciousness—Doxorubicin—lung cancer	6.77e-05	0.000202	CcSEcCtD
Zoledronate—Cough—Doxorubicin—lung cancer	6.73e-05	0.0002	CcSEcCtD
Zoledronate—FDPS—Metabolism—NQO1—lung cancer	6.7e-05	0.00115	CbGpPWpGaD
Zoledronate—Convulsion—Doxorubicin—lung cancer	6.68e-05	0.000199	CcSEcCtD
Zoledronate—Dizziness—Docetaxel—lung cancer	6.67e-05	0.000198	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	6.67e-05	0.00115	CbGpPWpGaD
Zoledronate—Hypertension—Doxorubicin—lung cancer	6.65e-05	0.000198	CcSEcCtD
Zoledronate—CA2—Metabolism—ALDOA—lung cancer	6.62e-05	0.00114	CbGpPWpGaD
Zoledronate—Musculoskeletal discomfort—Methotrexate—lung cancer	6.62e-05	0.000197	CcSEcCtD
Zoledronate—Insomnia—Methotrexate—lung cancer	6.57e-05	0.000195	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	6.56e-05	0.00113	CbGpPWpGaD
Zoledronate—Arthralgia—Doxorubicin—lung cancer	6.56e-05	0.000195	CcSEcCtD
Zoledronate—Myalgia—Doxorubicin—lung cancer	6.56e-05	0.000195	CcSEcCtD
Zoledronate—Chest pain—Doxorubicin—lung cancer	6.56e-05	0.000195	CcSEcCtD
Zoledronate—Anxiety—Doxorubicin—lung cancer	6.54e-05	0.000195	CcSEcCtD
Zoledronate—CA12—Metabolism—CYP2E1—lung cancer	6.54e-05	0.00112	CbGpPWpGaD
Zoledronate—Paraesthesia—Methotrexate—lung cancer	6.52e-05	0.000194	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.52e-05	0.000194	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	6.5e-05	0.00112	CbGpPWpGaD
Zoledronate—Discomfort—Doxorubicin—lung cancer	6.48e-05	0.000193	CcSEcCtD
Zoledronate—Dyspnoea—Methotrexate—lung cancer	6.48e-05	0.000193	CcSEcCtD
Zoledronate—CA12—Metabolism—NQO1—lung cancer	6.46e-05	0.00111	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ADCY1—lung cancer	6.46e-05	0.00111	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ABCG2—lung cancer	6.46e-05	0.00111	CbGpPWpGaD
Zoledronate—Somnolence—Methotrexate—lung cancer	6.46e-05	0.000192	CcSEcCtD
Zoledronate—CA2—Metabolism—NCOA3—lung cancer	6.43e-05	0.00111	CbGpPWpGaD
Zoledronate—Dry mouth—Doxorubicin—lung cancer	6.42e-05	0.000191	CcSEcCtD
Zoledronate—Vomiting—Docetaxel—lung cancer	6.41e-05	0.000191	CcSEcCtD
Zoledronate—CA14—Metabolism—GSTP1—lung cancer	6.4e-05	0.0011	CbGpPWpGaD
Zoledronate—Dyspepsia—Methotrexate—lung cancer	6.39e-05	0.00019	CcSEcCtD
Zoledronate—Rash—Docetaxel—lung cancer	6.36e-05	0.000189	CcSEcCtD
Zoledronate—Dermatitis—Docetaxel—lung cancer	6.35e-05	0.000189	CcSEcCtD
Zoledronate—Confusional state—Doxorubicin—lung cancer	6.34e-05	0.000189	CcSEcCtD
Zoledronate—Decreased appetite—Methotrexate—lung cancer	6.32e-05	0.000188	CcSEcCtD
Zoledronate—Headache—Docetaxel—lung cancer	6.31e-05	0.000188	CcSEcCtD
Zoledronate—Oedema—Doxorubicin—lung cancer	6.29e-05	0.000187	CcSEcCtD
Zoledronate—Anaphylactic shock—Doxorubicin—lung cancer	6.29e-05	0.000187	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Methotrexate—lung cancer	6.27e-05	0.000187	CcSEcCtD
Zoledronate—Fatigue—Methotrexate—lung cancer	6.26e-05	0.000186	CcSEcCtD
Zoledronate—CA2—Metabolism—ADCY1—lung cancer	6.25e-05	0.00108	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ABCG2—lung cancer	6.25e-05	0.00108	CbGpPWpGaD
Zoledronate—Infection—Doxorubicin—lung cancer	6.25e-05	0.000186	CcSEcCtD
Zoledronate—CA14—Metabolism—CAT—lung cancer	6.23e-05	0.00107	CbGpPWpGaD
Zoledronate—Pain—Methotrexate—lung cancer	6.21e-05	0.000185	CcSEcCtD
Zoledronate—ABCC1—Metabolism—HSD17B10—lung cancer	6.2e-05	0.00107	CbGpPWpGaD
Zoledronate—Shock—Doxorubicin—lung cancer	6.19e-05	0.000184	CcSEcCtD
Zoledronate—Nervous system disorder—Doxorubicin—lung cancer	6.17e-05	0.000184	CcSEcCtD
Zoledronate—Thrombocytopenia—Doxorubicin—lung cancer	6.16e-05	0.000183	CcSEcCtD
Zoledronate—Tachycardia—Doxorubicin—lung cancer	6.14e-05	0.000183	CcSEcCtD
Zoledronate—ABCC1—Disease—PGAM1—lung cancer	6.13e-05	0.00105	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ENO2—lung cancer	6.13e-05	0.00105	CbGpPWpGaD
Zoledronate—CA2—Metabolism—HPGDS—lung cancer	6.13e-05	0.00105	CbGpPWpGaD
Zoledronate—Skin disorder—Doxorubicin—lung cancer	6.11e-05	0.000182	CcSEcCtD
Zoledronate—CA2—Metabolism—PPP2R1B—lung cancer	6.09e-05	0.00105	CbGpPWpGaD
Zoledronate—Hyperhidrosis—Doxorubicin—lung cancer	6.08e-05	0.000181	CcSEcCtD
Zoledronate—CA14—Metabolism—ABCB1—lung cancer	6.06e-05	0.00104	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—STK11—lung cancer	6.04e-05	0.00104	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—TF—lung cancer	6.01e-05	0.00103	CbGpPWpGaD
Zoledronate—Anorexia—Doxorubicin—lung cancer	6e-05	0.000178	CcSEcCtD
Zoledronate—Nausea—Docetaxel—lung cancer	5.99e-05	0.000178	CcSEcCtD
Zoledronate—Feeling abnormal—Methotrexate—lung cancer	5.99e-05	0.000178	CcSEcCtD
Zoledronate—CA2—Metabolism—GSTT1—lung cancer	5.95e-05	0.00102	CbGpPWpGaD
Zoledronate—CA14—Metabolism—TYMS—lung cancer	5.95e-05	0.00102	CbGpPWpGaD
Zoledronate—Gastrointestinal pain—Methotrexate—lung cancer	5.94e-05	0.000177	CcSEcCtD
Zoledronate—GGPS1—Metabolism—PTEN—lung cancer	5.92e-05	0.00102	CbGpPWpGaD
Zoledronate—CA14—Metabolism—GSTM1—lung cancer	5.88e-05	0.00101	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GCLC—lung cancer	5.88e-05	0.00101	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP2A6—lung cancer	5.88e-05	0.00101	CbGpPWpGaD
Zoledronate—Hypotension—Doxorubicin—lung cancer	5.88e-05	0.000175	CcSEcCtD
Zoledronate—CA12—Metabolism—STK11—lung cancer	5.83e-05	0.001	CbGpPWpGaD
Zoledronate—Urticaria—Methotrexate—lung cancer	5.77e-05	0.000172	CcSEcCtD
Zoledronate—ABCC1—Metabolism—CKB—lung cancer	5.76e-05	0.000991	CbGpPWpGaD
Zoledronate—Abdominal pain—Methotrexate—lung cancer	5.74e-05	0.000171	CcSEcCtD
Zoledronate—Body temperature increased—Methotrexate—lung cancer	5.74e-05	0.000171	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.73e-05	0.000171	CcSEcCtD
Zoledronate—ABCC1—Disease—SDC4—lung cancer	5.73e-05	0.000985	CbGpPWpGaD
Zoledronate—Insomnia—Doxorubicin—lung cancer	5.69e-05	0.000169	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—lung cancer	5.67e-05	0.000976	CbGpPWpGaD
Zoledronate—Paraesthesia—Doxorubicin—lung cancer	5.65e-05	0.000168	CcSEcCtD
Zoledronate—GGPS1—Metabolism—EP300—lung cancer	5.64e-05	0.000971	CbGpPWpGaD
Zoledronate—Dyspnoea—Doxorubicin—lung cancer	5.61e-05	0.000167	CcSEcCtD
Zoledronate—Somnolence—Doxorubicin—lung cancer	5.59e-05	0.000166	CcSEcCtD
Zoledronate—FDPS—Metabolism—GSTP1—lung cancer	5.59e-05	0.000962	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ENO1—lung cancer	5.57e-05	0.000959	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CYP1A1—lung cancer	5.57e-05	0.000959	CbGpPWpGaD
Zoledronate—Dyspepsia—Doxorubicin—lung cancer	5.54e-05	0.000165	CcSEcCtD
Zoledronate—CA14—Metabolism—ERCC2—lung cancer	5.53e-05	0.000951	CbGpPWpGaD
Zoledronate—Decreased appetite—Doxorubicin—lung cancer	5.47e-05	0.000163	CcSEcCtD
Zoledronate—FDPS—Metabolism—CAT—lung cancer	5.44e-05	0.000936	CbGpPWpGaD
Zoledronate—Gastrointestinal disorder—Doxorubicin—lung cancer	5.43e-05	0.000162	CcSEcCtD
Zoledronate—Fatigue—Doxorubicin—lung cancer	5.42e-05	0.000161	CcSEcCtD
Zoledronate—ABCC1—Metabolism—CNDP2—lung cancer	5.42e-05	0.000932	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTM2—lung cancer	5.42e-05	0.000932	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—EP300—lung cancer	5.41e-05	0.00093	CbGpPWpGaD
Zoledronate—CA12—Metabolism—GSTP1—lung cancer	5.39e-05	0.000927	CbGpPWpGaD
Zoledronate—Pain—Doxorubicin—lung cancer	5.38e-05	0.00016	CcSEcCtD
Zoledronate—Constipation—Doxorubicin—lung cancer	5.38e-05	0.00016	CcSEcCtD
Zoledronate—Hypersensitivity—Methotrexate—lung cancer	5.35e-05	0.000159	CcSEcCtD
Zoledronate—FDPS—Metabolism—ABCB1—lung cancer	5.29e-05	0.00091	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTMR3—lung cancer	5.27e-05	0.000906	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CAT—lung cancer	5.25e-05	0.000902	CbGpPWpGaD
Zoledronate—Asthenia—Methotrexate—lung cancer	5.21e-05	0.000155	CcSEcCtD
Zoledronate—FDPS—Metabolism—TYMS—lung cancer	5.2e-05	0.000894	CbGpPWpGaD
Zoledronate—Feeling abnormal—Doxorubicin—lung cancer	5.18e-05	0.000154	CcSEcCtD
Zoledronate—Gastrointestinal pain—Doxorubicin—lung cancer	5.14e-05	0.000153	CcSEcCtD
Zoledronate—Pruritus—Methotrexate—lung cancer	5.14e-05	0.000153	CcSEcCtD
Zoledronate—FDPS—Metabolism—GSTM1—lung cancer	5.14e-05	0.000884	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PGAM1—lung cancer	5.14e-05	0.000883	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ABCB1—lung cancer	5.1e-05	0.000878	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SKI—lung cancer	5.05e-05	0.000869	CbGpPWpGaD
Zoledronate—CA12—Metabolism—TYMS—lung cancer	5.01e-05	0.000862	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP2E1—lung cancer	5e-05	0.00086	CbGpPWpGaD
Zoledronate—Urticaria—Doxorubicin—lung cancer	5e-05	0.000149	CcSEcCtD
Zoledronate—Body temperature increased—Doxorubicin—lung cancer	4.97e-05	0.000148	CcSEcCtD
Zoledronate—Abdominal pain—Doxorubicin—lung cancer	4.97e-05	0.000148	CcSEcCtD
Zoledronate—Diarrhoea—Methotrexate—lung cancer	4.97e-05	0.000148	CcSEcCtD
Zoledronate—CA12—Metabolism—GSTM1—lung cancer	4.95e-05	0.000852	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NQO1—lung cancer	4.94e-05	0.00085	CbGpPWpGaD
Zoledronate—ABCC1—Disease—B4GALT5—lung cancer	4.9e-05	0.000843	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2A7—lung cancer	4.9e-05	0.000843	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CYP1A1—lung cancer	4.87e-05	0.000838	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ERCC2—lung cancer	4.83e-05	0.000831	CbGpPWpGaD
Zoledronate—Dizziness—Methotrexate—lung cancer	4.8e-05	0.000143	CcSEcCtD
Zoledronate—ABCC1—Metabolism—SDC4—lung cancer	4.79e-05	0.000825	CbGpPWpGaD
Zoledronate—CA14—Metabolism—APOA1—lung cancer	4.78e-05	0.000822	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP1A1—lung cancer	4.7e-05	0.000808	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ERCC2—lung cancer	4.66e-05	0.000801	CbGpPWpGaD
Zoledronate—Hypersensitivity—Doxorubicin—lung cancer	4.63e-05	0.000138	CcSEcCtD
Zoledronate—Vomiting—Methotrexate—lung cancer	4.62e-05	0.000137	CcSEcCtD
Zoledronate—Rash—Methotrexate—lung cancer	4.58e-05	0.000136	CcSEcCtD
Zoledronate—Dermatitis—Methotrexate—lung cancer	4.58e-05	0.000136	CcSEcCtD
Zoledronate—Headache—Methotrexate—lung cancer	4.55e-05	0.000135	CcSEcCtD
Zoledronate—Asthenia—Doxorubicin—lung cancer	4.51e-05	0.000134	CcSEcCtD
Zoledronate—CA2—Metabolism—STK11—lung cancer	4.46e-05	0.000766	CbGpPWpGaD
Zoledronate—Pruritus—Doxorubicin—lung cancer	4.45e-05	0.000132	CcSEcCtD
Zoledronate—ABCC1—Disease—PXN—lung cancer	4.39e-05	0.000754	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—RRM1—lung cancer	4.37e-05	0.000751	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTA3—lung cancer	4.37e-05	0.000751	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CG—lung cancer	4.37e-05	0.000751	CbGpPWpGaD
Zoledronate—Nausea—Methotrexate—lung cancer	4.32e-05	0.000128	CcSEcCtD
Zoledronate—Diarrhoea—Doxorubicin—lung cancer	4.3e-05	0.000128	CcSEcCtD
Zoledronate—ABCC1—Disease—AKR1C1—lung cancer	4.29e-05	0.000739	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—APOA1—lung cancer	4.18e-05	0.000719	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—PIK3CA—lung cancer	4.18e-05	0.000718	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—AVP—lung cancer	4.16e-05	0.000716	CbGpPWpGaD
Zoledronate—Dizziness—Doxorubicin—lung cancer	4.16e-05	0.000124	CcSEcCtD
Zoledronate—CA14—Metabolism—POMC—lung cancer	4.16e-05	0.000715	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTP1—lung cancer	4.12e-05	0.000709	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—B4GALT5—lung cancer	4.11e-05	0.000706	CbGpPWpGaD
Zoledronate—CA14—Metabolism—CREBBP—lung cancer	4.05e-05	0.000696	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ABCB1—lung cancer	4.03e-05	0.000694	CbGpPWpGaD
Zoledronate—CA12—Metabolism—APOA1—lung cancer	4.03e-05	0.000693	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CAT—lung cancer	4.01e-05	0.00069	CbGpPWpGaD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4e-05	0.000688	CbGpPWpGaD
Zoledronate—Vomiting—Doxorubicin—lung cancer	4e-05	0.000119	CcSEcCtD
Zoledronate—ABCC1—Metabolism—GSTA4—lung cancer	3.99e-05	0.000687	CbGpPWpGaD
Zoledronate—Rash—Doxorubicin—lung cancer	3.97e-05	0.000118	CcSEcCtD
Zoledronate—Dermatitis—Doxorubicin—lung cancer	3.96e-05	0.000118	CcSEcCtD
Zoledronate—ABCC1—Disease—NPPA—lung cancer	3.95e-05	0.00068	CbGpPWpGaD
Zoledronate—Headache—Doxorubicin—lung cancer	3.94e-05	0.000117	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	3.9e-05	0.000671	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ABCB1—lung cancer	3.9e-05	0.000671	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTA2—lung cancer	3.89e-05	0.000669	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PPIA—lung cancer	3.86e-05	0.000663	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CD—lung cancer	3.84e-05	0.00066	CbGpPWpGaD
Zoledronate—CA2—Metabolism—TYMS—lung cancer	3.83e-05	0.000659	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ALDOA—lung cancer	3.83e-05	0.000658	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CG—lung cancer	3.82e-05	0.000656	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTM1—lung cancer	3.79e-05	0.000652	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ALB—lung cancer	3.79e-05	0.000652	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTA1—lung cancer	3.76e-05	0.000646	CbGpPWpGaD
Zoledronate—Nausea—Doxorubicin—lung cancer	3.74e-05	0.000111	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ABCC3—lung cancer	3.71e-05	0.000639	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CG—lung cancer	3.68e-05	0.000633	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—POMC—lung cancer	3.63e-05	0.000625	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ADCY1—lung cancer	3.61e-05	0.000622	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKR1C1—lung cancer	3.6e-05	0.000618	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP1A1—lung cancer	3.59e-05	0.000618	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ERCC2—lung cancer	3.56e-05	0.000613	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ENO2—lung cancer	3.54e-05	0.00061	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—CREBBP—lung cancer	3.54e-05	0.000608	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SMARCA4—lung cancer	3.52e-05	0.000606	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PPP2R1B—lung cancer	3.52e-05	0.000606	CbGpPWpGaD
Zoledronate—CA12—Metabolism—POMC—lung cancer	3.5e-05	0.000602	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—UGT1A1—lung cancer	3.49e-05	0.0006	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CREBBP—lung cancer	3.41e-05	0.000587	CbGpPWpGaD
Zoledronate—GGPS1—Metabolism—AKT1—lung cancer	3.41e-05	0.000587	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GNG11—lung cancer	3.37e-05	0.000579	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CD—lung cancer	3.35e-05	0.000577	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—APOA1—lung cancer	3.35e-05	0.000576	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CB—lung cancer	3.34e-05	0.000575	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTGS2—lung cancer	3.31e-05	0.00057	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—ALB—lung cancer	3.31e-05	0.000569	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CD—lung cancer	3.23e-05	0.000556	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ENO1—lung cancer	3.22e-05	0.000554	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALDOA—lung cancer	3.21e-05	0.000551	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ALB—lung cancer	3.19e-05	0.000549	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—APOA1—lung cancer	3.18e-05	0.000548	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NCOA3—lung cancer	3.11e-05	0.000535	CbGpPWpGaD
Zoledronate—CA2—Metabolism—APOA1—lung cancer	3.08e-05	0.00053	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	3.06e-05	0.000526	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ADCY1—lung cancer	3.03e-05	0.000521	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCG2—lung cancer	3.03e-05	0.000521	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APP—lung cancer	2.99e-05	0.000515	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF9—lung cancer	2.97e-05	0.000511	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ENO2—lung cancer	2.97e-05	0.000511	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HPGDS—lung cancer	2.97e-05	0.000511	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PPP2R1B—lung cancer	2.95e-05	0.000507	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CB—lung cancer	2.92e-05	0.000503	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.91e-05	0.000501	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS2—lung cancer	2.9e-05	0.000498	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PTEN—lung cancer	2.89e-05	0.000497	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTT1—lung cancer	2.88e-05	0.000495	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2A6—lung cancer	2.85e-05	0.000489	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GCLC—lung cancer	2.85e-05	0.000489	CbGpPWpGaD
Zoledronate—ABCC1—Disease—JUNB—lung cancer	2.84e-05	0.000488	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.83e-05	0.000488	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CB—lung cancer	2.82e-05	0.000485	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CG—lung cancer	2.81e-05	0.000484	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS2—lung cancer	2.79e-05	0.00048	CbGpPWpGaD
Zoledronate—CA14—Metabolism—EP300—lung cancer	2.76e-05	0.000474	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ENO1—lung cancer	2.7e-05	0.000464	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—CREBBP—lung cancer	2.7e-05	0.000464	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.69e-05	0.000462	CbGpPWpGaD
Zoledronate—CA2—Metabolism—POMC—lung cancer	2.68e-05	0.000461	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.65e-05	0.000456	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CREBBP—lung cancer	2.61e-05	0.000449	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTEN—lung cancer	2.53e-05	0.000435	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ALB—lung cancer	2.52e-05	0.000434	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FOXO3—lung cancer	2.49e-05	0.000427	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CD—lung cancer	2.47e-05	0.000425	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALB—lung cancer	2.44e-05	0.00042	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTEN—lung cancer	2.44e-05	0.000419	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2E1—lung cancer	2.42e-05	0.000416	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—EP300—lung cancer	2.41e-05	0.000414	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NQO1—lung cancer	2.39e-05	0.000412	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	2.34e-05	0.000403	CbGpPWpGaD
Zoledronate—CA12—Metabolism—EP300—lung cancer	2.32e-05	0.0004	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	2.32e-05	0.000399	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—RAF1—lung cancer	2.28e-05	0.000392	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HES1—lung cancer	2.2e-05	0.000379	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—STK11—lung cancer	2.16e-05	0.000371	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CB—lung cancer	2.16e-05	0.000371	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS2—lung cancer	2.14e-05	0.000367	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERCC2—lung cancer	2.06e-05	0.000354	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CA—lung cancer	2.04e-05	0.000351	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	2.02e-05	0.000348	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERBB3—lung cancer	2.01e-05	0.000346	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTP1—lung cancer	2e-05	0.000343	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CAT—lung cancer	1.94e-05	0.000334	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.93e-05	0.000332	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TERT—lung cancer	1.93e-05	0.000332	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCB1—lung cancer	1.89e-05	0.000325	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGFR1—lung cancer	1.87e-05	0.000322	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTEN—lung cancer	1.86e-05	0.00032	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TYMS—lung cancer	1.86e-05	0.000319	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HIF1A—lung cancer	1.85e-05	0.000317	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTM1—lung cancer	1.83e-05	0.000315	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CA—lung cancer	1.78e-05	0.000307	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APOA1—lung cancer	1.78e-05	0.000306	CbGpPWpGaD
Zoledronate—CA2—Metabolism—EP300—lung cancer	1.78e-05	0.000305	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP1A1—lung cancer	1.74e-05	0.000299	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ERCC2—lung cancer	1.72e-05	0.000297	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CA—lung cancer	1.72e-05	0.000296	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKT1—lung cancer	1.67e-05	0.000286	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APC—lung cancer	1.63e-05	0.00028	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KIT—lung cancer	1.63e-05	0.00028	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EGF—lung cancer	1.61e-05	0.000276	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BRAF—lung cancer	1.53e-05	0.000263	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6R—lung cancer	1.51e-05	0.00026	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CREBBP—lung cancer	1.51e-05	0.000259	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—APOA1—lung cancer	1.49e-05	0.000257	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKT1—lung cancer	1.46e-05	0.00025	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAP2K1—lung cancer	1.44e-05	0.000247	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CD—lung cancer	1.43e-05	0.000246	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.43e-05	0.000246	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKT1—lung cancer	1.4e-05	0.000241	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CG—lung cancer	1.36e-05	0.000234	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CA—lung cancer	1.31e-05	0.000226	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—POMC—lung cancer	1.3e-05	0.000223	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MDM2—lung cancer	1.28e-05	0.00022	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RAF1—lung cancer	1.28e-05	0.000219	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CREBBP—lung cancer	1.26e-05	0.000217	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERBB2—lung cancer	1.26e-05	0.000217	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTOR—lung cancer	1.25e-05	0.000214	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CB—lung cancer	1.25e-05	0.000214	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CD4—lung cancer	1.24e-05	0.000214	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTGS2—lung cancer	1.23e-05	0.000212	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CD—lung cancer	1.2e-05	0.000206	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALB—lung cancer	1.18e-05	0.000203	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1A—lung cancer	1.08e-05	0.000186	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTEN—lung cancer	1.08e-05	0.000185	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKT1—lung cancer	1.07e-05	0.000185	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CB—lung cancer	1.04e-05	0.000179	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS2—lung cancer	1.03e-05	0.000178	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EP300—lung cancer	1.03e-05	0.000177	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SRC—lung cancer	9.98e-06	0.000172	CbGpPWpGaD
Zoledronate—ABCC1—Disease—STAT3—lung cancer	9.63e-06	0.000166	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NRAS—lung cancer	9.61e-06	0.000165	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAPK3—lung cancer	9.2e-06	0.000158	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTEN—lung cancer	9.02e-06	0.000155	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MYC—lung cancer	8.95e-06	0.000154	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EGFR—lung cancer	8.75e-06	0.000151	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—EP300—lung cancer	8.6e-06	0.000148	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KRAS—lung cancer	8.27e-06	0.000142	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CA—lung cancer	7.6e-06	0.000131	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HRAS—lung cancer	7.03e-06	0.000121	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6—lung cancer	6.73e-06	0.000116	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CA—lung cancer	6.36e-06	0.000109	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT1—lung cancer	6.2e-06	0.000107	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKT1—lung cancer	5.2e-06	8.94e-05	CbGpPWpGaD
